In this episode, we speak with Björn Schimmöller, Co-Founder and CEO of iuvantium, a synthetic immunobiology company developing new modalities for the next generation of immunotherapies.
Host: Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
The founding journey of...
Published 01/17/24
In this episode, we speak with Ashwini Ghogare, Head of Artificial Intelligence and Automation in Drug Discovery at MilliporeSigma, the Global Science and Technology Group at Merck.
Host: Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
About Ashwini’s journey to her...
Published 12/11/23